What is the clinical evidence from this study?

Study design: Observational. Population: Diabetes mellitus and acute myocardial infarction (n=130). Intervention: NSTEMI vs. STEMI. Primary outcome: Treatment with invasive methods (p=<0.001).

What does this research mean for the field?

Diabetic patients presenting with NSTEMI are treated with invasive methods significantly less frequently than those with STEMI, despite having higher rates of prior PCI and left main disease. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 1, 2016Advances in Clinical and Experimental MedicineOpen Access

Diabetic Patients with an Acute Myocardial Infarction in Terms of Risk Factors and Comorbidities Management: Characteristics of the Highest-Risk Individuals

Q: What are the key findings of this study?

Diabetic patients with NSTEMI were treated with invasive methods less frequently than those with STEMI (75% vs. 95.5%; p<0.001), despite having a higher rate of previous PCI.

Q: What does this research mean for the field?

Diabetic patients presenting with NSTEMI are treated with invasive methods significantly less frequently than those with STEMI, despite having higher rates of prior PCI and left main disease. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

View Full Paper

Ask AI

Bookmark

Key result

Diabetic NSTEMI patients undergo invasive treatment ~21% less often than STEMI patients, despite more prior PCI.

P<0.001
n=130

Population

130 patients with diabetes mellitus and acute myocardial infarction, hospitalized in a single center in…

Design

Cohort

Authors

JDJózefa DąbekMedical University of Silesia MBMariusz BałysMedical University of Silesia MMMichał MajewskiUniversity of Life Sciences in Poznań

Discussion

Member takes

Implication

Diabetic NSTEMI patients receive less invasive management than STEMI counterparts; leaves open whether diabetes-specific strategies improve outcomes.

Study Design

Type

Observational (n=130)

Multicenter

Structured PICO

Population

130 patients with diabetes mellitus and acute myocardial infarction hospitalized at a single center in Poland in 2012.

Outcome

Clinical presentation, medical history, laboratory tests, imaging studies, and treatment management differences between STEMI and NSTEMI

Main Result

Absolute Event Rate: 75% vs 95.5%

p-value: p=<0.001

Diabetic patients with AMI present more frequently with NSTEMI, though STEMI patients exhibit higher inflammatory and metabolic markers and receive more frequent invasive management.

Cite This Study

Dąbek et al. (2016) conducted an observational in Diabetes mellitus and acute myocardial infarction (n=130). NSTEMI vs. STEMI was evaluated on Treatment with invasive methods (p=<0.001). Diabetic patients with NSTEMI were treated with invasive methods less frequently than those with STEMI (75% vs. 95.5%; p<0.001), despite having a higher rate of previous PCI.

synapsesocial.com/papers/6aa50f101492f90b230a57cb https://doi.org/10.17219/acem/58785

View Full Paper

Ask AI

Bookmark

Implication

Diabetic NSTEMI patients receive less invasive management than STEMI counterparts; leaves open whether diabetes-specific strategies improve outcomes.

Diabetic Patients with an Acute Myocardial Infarction in Terms of Risk Factors and Comorbidities Management: Characteristics of the Highest-Risk Individuals

Discussion

Member takes

Implication

Study Design

Structured PICO

Main Result

Cite This Study

Diabetic Patients with an Acute Myocardial Infarction in Terms of Risk Factors and Comorbidities Management: Characteristics of the Highest-Risk Individuals

Discussion

Member takes

Implication

Study Design

Structured PICO

Main Result

Cite This Study

Also Consider

Also Consider